scholarly journals First‐in‐Human Proof‐of‐Concept Study: Intralesional Administration of BQ788, an Endothelin Receptor B Antagonist, to Melanoma Skin Metastases

2015 ◽  
Vol 20 (10) ◽  
pp. 1121-1122 ◽  
Author(s):  
Jasper Wouters ◽  
Robert E. Hunger ◽  
Terence Garrod ◽  
Benoit Dubuis ◽  
Thomas Hunziker ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document